David P Molkentine (David Molkentine)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Radiation Induced

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Phillip M Pifer, Liangpeng Yang, Manish Kumar, Tongxin Xie, Mitchell J Frederick, Andrew Hefner, Beth M Beadle, David P Molkentine, Jessica M Molkentine, Annika Dhawan, Mohamed K Abdelhakiem, Abdullah A Osman, Brian J Leibowitz, Jeffrey N Myers, Curtis R Pickering, Vlad C Sandulache, John Victor Heymach, Heath D Skinner
FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Natalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, David P Molkentine, Santiago Treviño, Vitaly Druker, Yu Qian, Sonia A Patel, Stephanie Tzouanas Schmidt, Lingzhi Hong, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jiun-Kae Jack Lee, Marcelo Vailati Negrão, Don L Gibbons, Ara A Vaporciyan, Xiuning Li, Jia Wu, Jianjun Zhang, Una Rigney, Sonia Iyer, Emma Dean, John Victor Heymach
ATM mutations associate with distinct co-mutational patterns and therapeutic vulnerabilities in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
David P Molkentine, Jessica M Molkentine, Kathleen A Bridges, David R Valdecanas, Annika Dhawan, Reshub Bahri, Andrew J Hefner, Manish Kumar, Liangpeng Yang, Mohamed K Abdelhakiem, Phillip M Pifer, Vlad Sandulache, Aakash Sheth, Beth M Beadle, Howard D Thames, Kathryn A Mason, Curtis R Pickering, Raymond E Meyn, Heath D Skinner
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer research 82 (5) (2022)
Manish Kumar, David P Molkentine, Jessica M Molkentine, Kathleen Bridges, Tongxin Xie, Liangpeng Yang, Andrew Hefner, Meng Gao, Reshub Bahri, Annika Dhawan, Mitchell J Frederick, Sahil B Seth, Mohamed K Abdelhakiem, Beth M Beadle, Faye M Johnson, Jing Wang, Li Shen, Timothy P Heffernan, Aakash Sheth, Robert L Ferris, Jeffrey N Myers, Curtis R Pickering, Heath D Skinner
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Nature communications 12 (1) (2021)